Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Primus E Mullis

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|July 27, 2016
Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type IIMaria Consolata Miletta, Christa E Flück, Primus-E Mullis
Hormone Research in Paediatrics|June 3, 2010
Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancyCatherine Peters, Shirley Langham, Primus E Mullis, et al.
Swiss Medical Weekly|September 21, 2010
High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetesMarco Janner, Pietro Ballinari, Primus E Mullis, et al.
Hormone Research|October 8, 2005
Absent or delayed adrenarche in Pit-1/POU1F1 deficiencyDoris Taha, Primus E Mullis, Lourdes Ibáñez, et al.
Endocrine Development|November 28, 2012
Isolated growth hormone deficiency type 2: from gene to therapyMaria Consolata Miletta, Didier Lochmatter, Vibor Pektovic, et al.
Molecular Pharmacology|December 2, 2006
Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2Petra Kempná, Gaby Hofer, Primus E Mullis, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|June 6, 2003
Training modalities: over-reaching and over-training in athletes, including a study of the role of hormonesMartin Hug, Primus E Mullis, Michael Vogt, et al.
Hormone Research|February 24, 2006
Impact of del32-71-GH (exon 3 skipped GH) on intracellular GH distribution, secretion and cell viability: a quantitative confocal microscopy analysisSouzan Salemi, Shida Yousefi, Andrée Eblé, et al.
European Journal of Endocrinology|June 24, 2006
Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 proteinMarco Janner, Amit V Pandey, Primus E Mullis, et al.
Molecular and Cellular Endocrinology|March 2, 2010
Restoration of mutant cytochrome P450 reductase activity by external flavinCatherine Nicolo, Christa E Flück, Primus E Mullis, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|July 27, 2016
Targeting GH-1 splicing as a novel pharmacological strategy for growth hormone deficiency type IIMaria Consolata Miletta, Christa E Flück, Primus-E Mullis
Hormone Research in Paediatrics|June 3, 2010
Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancyCatherine Peters, Shirley Langham, Primus E Mullis, et al.
Swiss Medical Weekly|September 21, 2010
High prevalence of vitamin D deficiency in children and adolescents with type 1 diabetesMarco Janner, Pietro Ballinari, Primus E Mullis, et al.
Hormone Research|October 8, 2005
Absent or delayed adrenarche in Pit-1/POU1F1 deficiencyDoris Taha, Primus E Mullis, Lourdes Ibáñez, et al.
Endocrine Development|November 28, 2012
Isolated growth hormone deficiency type 2: from gene to therapyMaria Consolata Miletta, Didier Lochmatter, Vibor Pektovic, et al.
Molecular Pharmacology|December 2, 2006
Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2Petra Kempná, Gaby Hofer, Primus E Mullis, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|June 6, 2003
Training modalities: over-reaching and over-training in athletes, including a study of the role of hormonesMartin Hug, Primus E Mullis, Michael Vogt, et al.
Hormone Research|February 24, 2006
Impact of del32-71-GH (exon 3 skipped GH) on intracellular GH distribution, secretion and cell viability: a quantitative confocal microscopy analysisSouzan Salemi, Shida Yousefi, Andrée Eblé, et al.
European Journal of Endocrinology|June 24, 2006
Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 proteinMarco Janner, Amit V Pandey, Primus E Mullis, et al.
Molecular and Cellular Endocrinology|March 2, 2010
Restoration of mutant cytochrome P450 reductase activity by external flavinCatherine Nicolo, Christa E Flück, Primus E Mullis, et al.
Pageof 10